Thiocolchicoside inhibits the activity of various subtypes of recombinant GABAA receptors expressed in Xenopus laevis oocytes

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 37-42

  Mascia, Maria Paola ^a   Bachis, Elisabetta ^b   Obili, Nicola ^b   Maciocco, Elisabetta ^a   Cocco, Giovanni Antonio ^c   Sechi, Gian Pietro ^c   Biggio, Giovanni ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Neurological Clinic   (Italy)

Author keywords

GABAA receptor; Strychnine sensitive glycine receptor; Thiocolchicoside; Xenopus oocyte

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CHLORINE; GLYCINE RECEPTOR; NICOTINIC RECEPTOR; SEROTONIN 3 RECEPTOR; STRYCHNINE; THIOCOLCHICOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MEMBRANE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; ELECTROPHYSIOLOGY; EPILEPTOGENESIS; MALE; NEUROTRANSMISSION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; XENOPUS LAEVIS;

ANIMALS; COLCHICINE; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, GLYCINE; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN, 5-HT3; RECOMBINANT PROTEINS; XENOPUS LAEVIS;

EID: 33847273044     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.076     Document Type: Article

References (29)

1. 3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex. Eur. J. Pharmacol. 376 (1999) 149-157
2. 3H]thiocolchicoside binding sites in the rat brain and spinal cord. Neuropharmacology 40 (2001) 1044-1049
3. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., Braestrup C., Bateson A.N., and Langer S.Z. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50 (1998) 291-313
4. A receptor. Nat. Rev., Neurosci. 6 (2005) 565-575
5. Biziere K., Huguet F., Narcisse G., and Breteau M. Affinity of thiocolchicoside and thiocolchicoside analogues for the postsynaptic GABA receptor site. Eur. J. Pharmacol. 75 (1981) 167-168
6. Biziere K., Huguet F., Narcisse G., and Breteau M. Le thiocolchicoside, un agoniste des recepteurs GABAergiques. Therapie 36 (1981) 95
7. Bloomquist J.R. Chloride channels as tools for developing selective insecticides. Arch. Insect Biochem. Physiol. 54 (2003) 145-156
8. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 21 (2000) 16-19
9. Braestrup C., and Nielsen M. Discovery of beta-carboline ligands for benzodiazepine receptors. Psychopharmacol. Ser. 11 (1993) 1-6
10. A receptors independently of microtubule depolymerization. Neuropharmacology 37 (1998) 383-390
11. A receptor function in the central nervous system. Neuropharmacology 51 (2006) 805-815
12. Chebib M., and Johnston G.A. The 'ABC' of GABA receptors: a brief review. Clin. Exp. Pharmacol. Physiol. 26 (1999) 937-940
13. 3H]strychnine binding sites in rat spinal cord and brainstem. Eur. J. Pharmacol. 318 (1996) 201-204
14. Colman A. Expression of exogenous DNA in Xenopus oocytes. In: Hames B.D., and Higgins S.J. (Eds). Transcription and Translation: A Practical Approach (1984), Oxford University Press, Washington, DC 49-59
15. Dasheiff R.M., and Ramirez L.F. The effects of colchicine in mammalian brain from rodents to rhesus monkeys. Brain Res. 357 (1985) 47-67
16. De Deyn P.P., Marescau B., and MacDonald R.L. Epilepsy and the GABA hypothesis-a brief review and some examples. Acta Neurol. Belg. 90 (1990) 65-81
17. De Riu P.L., Rosati G., Sotgiu S., and Sechi G. Epileptic seizures after treatment with thiocolchicoside. Epilepsia 42 (2001) 1084-1086
18. A receptors. Nat. Rev., Neurosci. 6 (2005) 215-229
19. Janbroers J.M. Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic action. Acta Ther. 13 (1987) 221-250
20. Jensen A.A., Frolund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
21. Kehne J.H., Kane J.M., Miller F.P., Ketteler H.J., Braun D.L., Senyah Y., Chaney S.F., Abdallah A., Dudley M.W., Ogden A.M., and Palfreyman M.G. MDL 27,531 selectively reverses strychnine-induced seizures in mice. Br. J. Pharmacol. 106 (1992) 910-916
22. Lynch J.W. Molecular structure and function of the glycine receptor chloride channel. Physiol. Rev. 84 (2004) 1051-1095
23. Machu T.K. Colchicine competitively antagonizes glycine receptors expressed in Xenopus oocytes. Neuropharmacology 37 (1998) 391-396
24. Mascia M.P., Trudell J.R., and Harris R.A. Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9305-9310
25. A and glycine receptors. Nature 389 (1997) 385-389
26. Mohler H., Fritschy J.M., and Rudolph U. A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300 (2002) 2-8
27. A receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22 (2001) 188-194
28. Sechi G., De Riu P., Mameli O., Deiana G.A., Cocco G.A., and Rosati G. Focal and secondarily generalised convulsant status epilepticus induced by thiocolchicoside in the rat. Seizure 12 (2003) 508-515
29. A receptor diversity. Neuropharmacology 35 (1996) 1139-1160